RHINOCORT AQUA 64 MCG
BUDESONIDE : 64 MCG · DIN 02231923 · MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
Health Canada status: MARKETED
What is RHINOCORT AQUA?
RHINOCORT AQUA 64 MCG contains BUDESONIDE : 64 MCG. It is listed in the Health Canada Drug Product Database under DIN 02231923, held by MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC, supplied as SPRAY, METERED DOSE for NASAL administration. Health Canada currently lists it as marketed, status dated 09-Mar-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is RHINOCORT AQUA used for?
RHINOCORT® AQUA (Budesonide Aqueous Nasal Spray) is indicated for: • The treatment of seasonal allergic and allergic/non-allergic perennial and vasomotor rhinitis unresponsive to conventional therapy in patients 6 years and older • The treatment of nasal polyps and in the prevention of nasal polyps after polypectomy in patients 12 years and older
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02231923 |
|---|---|
| Brand name | RHINOCORT AQUA |
| Generic / active ingredient | BUDESONIDE : 64 MCG |
| Manufacturer | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC |
| Strength | 64 MCG |
| Dosage form | SPRAY, METERED DOSE |
| Route of administration | NASAL |
| Schedule | Prescription |
| ATC code | R01AD05 BUDESONIDE |
| AHFS class | 88:28.01* ; See footnote |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 09-Mar-2026 |
| Original market date | 1997-09-09 00:00:00 |
How is it stored and handled?
null
How is it supplied?
bottles of 120 doses
What can be used instead?
Other Canadian products sharing ATC code R01AD05 BUDESONIDE. 3 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MYLAN-BUDESONIDE AQ | 100 MCG | SPRAY, METERED DOSE | MYLAN PHARMACEUTICALS ULC | MARKETED | DIN 02230648 |
| MYLAN-BUDESONIDE AQ | 64 MCG | SPRAY, METERED DOSE | MYLAN PHARMACEUTICALS ULC | MARKETED | DIN 02241003 |
| RHINOCORT AQUA 100MCG | 100 MCG | METERED-DOSE AEROSOL | ASTRA PHARMA INC. | CANCELLED POST MARKET | DIN 01974432 |
| RHINOCORT TURBUHALER 100 MCG/DOSE | 100 MCG | POWDER | ASTRAZENECA CANADA INC | CANCELLED POST MARKET | DIN 02035324 |
Who else supplies BUDESONIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BUDESONIDE appears in 1002 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.